Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma

Published:2024-07 Issue: Volume: Page:
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Tajiri Tomoko^ORCID,Suzuki Motohiko,Nishiyama Hirono,Ozawa Yoshiyuki,Kurokawa Ryota,Ito Keima,Fukumitsu Kensuke,Mori Yuta,Kanemitsu Yoshihiro,Fukuda Satoshi,Uemura Takehiro,Ohkubo Hirotsugu,Takemura Masaya,Maeno Ken,Ito Yutaka,Oguri Tetsuya,Iwasaki Shinichi,Niimi Akio

Funder

Nagoya University Hospital

Publisher

Elsevier BV

Reference47 articles.

1. Dupilumab: basic aspects and applications to allergic diseases;Matsunaga;Allergol Int,2020

2. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials;Bachert;Lancet,2019

3. The effect of dupilumab on intractable chronic rhinosinusitis with nasal polyps in Japan;Fujieda;Laryngoscope,2021

4. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational Phase IV real-life study (DUPIREAL);De Corso;Allergy,2023

5. Effectiveness of dupilumab in the treatment of patients with uncontrolled severe CRSwNP: a “real-life” observational study in naïve and post-surgical patients;Ottaviano;J Pers Med,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP